Safety and Efficacy of Delayed-release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from Asia-Pacific and Other Countries: Interim Analysis of the APEX Extension Study

被引：0
|
作者：
Saida, Takahiko [1 ]
Yamamura, Takashi [2 ]
Kondo, Takayuki [3 ]
Yun, Jang [4 ]
Li, Jie [4 ]
Forsythe, Beverley [4 ]
Sheikh, Sarah, I [4 ]
Zhu, Bing [4 ]
机构：
[1] Kyoto Min Iren Cent Hosp, Kansai Multiple Sclerosis Ctr, Kyoto, Japan
[2] Natl Ctr Neurol & Psychiat NCNP, Tokyo, Japan
[3] Kansai Med Univ, Med Ctr, Osaka, Japan
[4] Biogen, Cambridge, MA USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5.363
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis - findings from a real-world setting in Russian Federation
    Davydovskaya, M.
    Pozhidaeva, N.
    Dubchenko, E.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 934 - 935
  • [32] Absolute Lymphocyte Count in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Delayed-release Dimethyl Fumarate: Considerations for Patient Management
    Fox, Robert
    Chan, Andrew
    Gold, Ralf
    Phillips, J. Theodore
    Yang, Lili
    Liu, Shifang
    Prada, Claudia
    Ray, Soma
    Mehta, Devangi
    Taylor, Catherine
    Fay, Monica
    NEUROLOGY, 2017, 88
  • [33] The effect of delayed-release dimethyl fumarate on lymphocyte subsets and immunoglobulins in patients with relapsing-remitting multiple sclerosis: Interim results of an open-label phase 3 study
    von Hehn, C.
    Mehta, D.
    Prada, C.
    Yang, L.
    Liu, S.
    Ray, S.
    Sheikh, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 416 - 416
  • [34] Efficacy of delayed-release dimethyl fumarate for relapsing-remitting multiple sclerosis (RRMS) in "non-responders'' to prior treatment with interferon beta
    Fernandez, O.
    Giovannoni, G.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Yang, M.
    Zhang, A.
    Kurukulasuriya, N. C.
    JOURNAL OF NEUROLOGY, 2014, 261 : S19 - S20
  • [35] Efficacy of delayed-release dimethyl fumarate in Japanese patients with relapsing multiple sclerosis in the placebo-controlled phase 3 apex study
    Kondo, T.
    Kawachi, I.
    Onizuka, Y.
    Hiramatsu, K.
    Hase, M.
    Yun, J.
    Ling, Y.
    Torii, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 439 - 440
  • [36] Efficacy of delayed-release dimethyl fumarate for relapsing-remitting multiple sclerosis (RRMS) in "non-responders" to prior treatment with interferon beta
    Fernandez, O.
    Giovannoni, G.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Yang, M.
    Zhang, A.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 25 - 25
  • [37] Efficacy and Tolerability of Delayed-release Dimethyl Fumarate in Black, Hispanic, and Asian Patients with Relapsing-Remitting Multiple Sclerosis: Post Hoc Integrated Analysis of DEFINE and CONFIRM
    Fox R.J.
    Gold R.
    Phillips J.T.
    Okwuokenye M.
    Zhang A.
    Marantz J.L.
    Neurology and Therapy, 2017, 6 (2) : 175 - 187
  • [38] Safety and Efficacy of Delayed-release Dimethyl Fumarate in Multiple Sclerosis Patients Treated in Routine Medical Practice: Interim Analysis of ESTEEM
    Everage, Nicholas J.
    Prada, Claudia
    Liu, Shifang
    Balashov, Konstantin
    Macdonell, Richard
    Windsheimer, Jorg
    Giles, Kathryn
    NEUROLOGY, 2017, 88
  • [39] Safety and efficacy of delayed-release dimethyl fumarate in multiple sclerosis patients treated in routine medical practice: interim analysis of ESTEEM
    Everage, N. J.
    Jones, C. C.
    Das, R.
    Hanna, J.
    Liu, S.
    Balashov, K.
    Macdonell, R.
    Windsheimer, J.
    Giles, K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 715 - 716
  • [40] Safety of delayed-release dimetyl fumarate in Japanese patients with relapsing multiple sclerosis: Subgroup analysis of the apex Part 1 study
    Ochi, H.
    Niino, M.
    Onizuka, Y.
    Hiramatsu, K.
    Hase, M.
    Yun, J.
    Ling, Y.
    Torii, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 791 - 792
12345